Related Experiment Video
Updated: May 21, 2026

Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction
Published on: October 6, 2022
Deregulation of Rab and Rab effector genes in bladder cancer
Joel R Ho1, Elodie Chapeaublanc, Lisa Kirkwood
1Institut Curie, Centre de Recherche, Paris, France.
Abstract:
Growing evidence indicates that Rab GTPases, key regulators of intracellular transport in eukaryotic cells, play an important role in cancer. We analysed the deregulation at the transcriptional level of the genes encoding Rab proteins and Rab-interacting proteins in bladder cancer pathogenesis, distinguishing between the two main progression pathways so far identified in bladder cancer: the Ta pathway characterized by a high frequency of FGFR3 mutation and the carcinoma in situ pathway where no or infrequent FGFR3 mutations have been identified. A systematic literature search identified 61 genes encoding Rab proteins and 223 genes encoding Rab-interacting proteins. Transcriptomic data were obtained for normal urothelium samples and for two independent bladder cancer data sets corresponding to 152 and 75 tumors. Gene deregulation was analysed with the SAM (significant analysis of microarray) test or the binomial test. Overall, 30 genes were down-regulated, and 13 were up-regulated in the tumor samples. Five of these deregulated genes (LEPRE1, MICAL2, RAB23, STXBP1, SYTL1) were specifically deregulated in FGFR3-non-mutated muscle-invasive tumors. No gene encoding a Rab or Rab-interacting protein was found to be specifically deregulated in FGFR3-mutated tumors. Cluster analysis showed that the RAB27 gene cluster (comprising the genes encoding RAB27 and its interacting partners) was deregulated and that this deregulation was associated with both pathways of bladder cancer pathogenesis. Finally, we found that the expression of KIF20A and ZWINT was associated with that of proliferation markers and that the expression of MLPH, MYO5B, RAB11A, RAB11FIP1, RAB20 and SYTL2 was associated with that of urothelial cell differentiation markers. This systematic analysis of Rab and Rab effector gene deregulation in bladder cancer, taking relevant tumor subgroups into account, provides insight into the possible roles of Rab proteins and their effectors in bladder cancer pathogenesis. This approach is applicable to other group of genes and types of cancer.
Insights
Rab GTPases are crucial for intracellular transport and play a role in cancer. This study analyzed Rab gene deregulation in bladder cancer, finding specific gene changes linked to tumor pathways and progression, offering insights into cancer pathogenesis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Rab GTPases are key regulators of intracellular transport.
- Dysregulation of Rab GTPases is implicated in various cancers.
- Bladder cancer exhibits distinct progression pathways, including FGFR3-mutated and non-mutated types.
Purpose of the Study:
- To analyze transcriptional deregulation of Rab proteins and interacting proteins in bladder cancer.
- To differentiate gene deregulation patterns between FGFR3-mutated and non-mutated bladder cancer pathways.
- To investigate the association of Rab gene expression with tumor proliferation and differentiation markers.
Main Methods:
- Systematic literature search for Rab and Rab-interacting proteins.
- Transcriptomic data analysis of normal urothelium and bladder tumors.
- Statistical analysis using SAM (significant analysis of microarray) test and binomial test.
- Cluster analysis to identify gene clusters associated with bladder cancer pathways.
Main Results:
- Overall, 30 genes were down-regulated and 13 up-regulated in bladder tumors.
- Five genes (LEPRE1, MICAL2, RAB23, STXBP1, SYTL1) were specifically deregulated in FGFR3-non-mutated muscle-invasive tumors.
- The RAB27 gene cluster was deregulated and associated with both bladder cancer pathways.
- Specific Rab gene expressions correlated with proliferation and differentiation markers.
Conclusions:
- Transcriptional deregulation of Rab and Rab-interacting genes is evident in bladder cancer.
- Specific Rab gene alterations are linked to distinct bladder cancer subtypes and progression.
- This systematic analysis provides insights into Rab protein roles in bladder cancer pathogenesis and suggests a broadly applicable methodology.
Related Concept Videos
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation
Rab Cascades
The Ras Gene
Ras is a superfamily...
